Indeks Fibroq Penderita Sirosis Hati Berdasarkan Besar Varises Esofagus
Lampiran 1 : Surat Persetujuan Komite Etik
Lampiran 2
LEMBAR PENJELASAN KEPADA CALON SUBJEK PENELITIAN
Assalamualaikum wr.Wb.
Salam sejahtera bagi Bapak/Ibu, Saudara/i,
Terima kasih atas kesediaan Bapak/Ibu, Saudara/i, meluangkan waktu untuk
membaca dan mengisi surat persetujuan ini. Sebelumnya, perkenankan saya
memperkenalkan diri. Nama saya dr. Adi Sumanta Sembiring G, peserta
Program Pendidikan Dokter Spesialis Ilmu Penyakit Dalam di Fakultas
Kedokteran Universitas Sumatera Utara (FK-USU). Saya sedang melakukan
pengumpulan data penelitian tugas akhir sebagai salah satu syarat
menyelesaikan pendidikan di FK-USU. Adapun judul penelitian saya adalah
“Hubungan Besar Varises Esofagus Secara Endoskopi Dengan INDEKS
FIBROQ Pada Penderita Sirosis hati.”
Penelitian ini bertujuan untuk mengetahui hubungan antara besar varises esofagus
secara endoskopi dengan INDEKS FIBROQ pada penderita sirosis hati dan untuk
melihat akurasi INDEKS FIBROQ dalam memprediksi ukuran varises esofagus
dengan endoskopi pada pasien sirosis hati.
Kepada bapak/ibu yang bersedia mengikuti penelitian ini nantinya akan
diminta mengisi surat persetujuan ikut dalam penelitian, mengikuti
wawancara dan menjalani pemeriksaan fisik.
Perlu saya ingatkan, keikutsertaan Bapak/Ibu, Saudara/i adalah sukarela dan
tidak dikenakan biaya. Semua data yang terkumpul saya jamin
kerahasiaannya. Bila keterangan yang saya berikan masih belum jelas,
Bapak/Ibu, Saudara/I dapat menanyakan langsung kepada saya :
Nama
: dr. Adi Sumanta Sembiring G
Alamat
: Jl. Bunga Ester Komp.Mobil Oil no.91D Medan
No.telp
: 085362129478
Atas perhatian Bapak/Ibu, Saudara/I saya ucapkan terima kasih.
Hormat saya,
dr.Adi Sumanta Sembiring G
Lampiran 3
SURAT PERSETUJUAN SETELAH PENJELASAN
(INFORMED CONSENT )
Saya yang bertanda tangan dibawah ini :
Nama
:...........................................................................................
Alamat
:...........................................................................................
Umur
:........................ Tahun
Jenis Kelamin : Laki-laki/ Perempuan*
No Telp/ HP
:
Setelah mendapat penjelasan dari peneliti tentang kebaikan dan keburukan
prosedur penelitian ini, menyatakan BERSEDIA ikut serta dalam penelitian
tentang ”Hubungan Besar Varises Esofagus Secara Endoskopi dengan
indeks FibroQ pada Penderita Sirosis Hati”. Apabila sewaktu-waktu saya
mengundurkan diri dari penelitian ini, kepada saya tidak dituntut apapun.
Demikianlah surat persetujuan bersedia ikut dalam penelitian ini saya buat, untuk
dapat digunakan seperlunya.
Medan, ...........................2014
Yang
pernyataan,
(................................)
*Coret yang tidak perlu
memberi
Lampiran 4
KERTAS KERJA PROFIL PESERTA PENELITIAN
DATA PESERTA
Tanggal:
MR
:
No. Peserta
:
I. IDENTITAS PRIBADI
Nama
:
Tempat/ Tanggal lahir/Usia
:
Jenis kelamin
: Laki-laki / Perempuan
Pendidikan terakhir
:
Pekerjaan
:
Status
Telp................
:
Faktor risiko
:
No. Telp/Hp
:
Kawin
/
Belum
II. PEMERIKSAAN FISIK
III. PEMERIKSAAN LABORATORIUM
Parameter
Trombosit (sel/mm3)
AST (U/L)
ALT (U/L)
INR
Nilai
Kawin.
No
IV. PEMERIKSAAN PENUNJANG.
Hasil USG Abdomen:
Hasil Endoskopi:
V. Indeks FIBROQ:
LAMPIRAN 5
DAFTAR RIWAYAT HIDUP
I.
DATA PRIBADI
Nama
Tempat/Tgl.lahir
Jenis kelamin
Agama
Pekerjaan
NRP
Pangkat/Gol.
Istri
Anak
Alamat pekerjaan
Alamat rumah
Telepon selular
II.
:
:
:
:
:
:
:
:
:
dr. Adi Sumanta Sembiring G
Binjai/ 02 Juli 1979
Laki-laki
Islam
Dokter/TNI
11040008960779
Kapten
Sri Rezekika Maulida, SS
M. Harun Adly S
Ahmad Lukman Adly S
Chairina Arsyifa Adly
: Direktorat Kesehatan Angkatan Darat,
Markas Besar Angkatan Darat, Jakarta
: Jl. Bunga Ester komp.Mobil Oil No.91 D Medan
20131
: 085362129478
PENDIDIKAN
1. SD Advent 4 (1985-1991) di Medan, Kotamadya Medan - Sumatera Utara
2. SMP Negeri 1 Medan (1991-1994) di Medan - Sumatera Utara
3. SMU PKMI 1 Medan(1994-1997) di Medan - Sumatera Utara
4. Fakultas Kedokteran Universitas Sumatera Utara (1997-2003) di Medan - Sumatera
Utara.
5. PPDS Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Sumatera Utara (2010sekarang) di Medan-Sumatera Utara
III.
RIWAYAT PEKERJAAN
1.
2.
3.
4.
IV.
Dokter Yonkav 3/Tank, Malang-Jatim 2004-2006.
Dokter Rumkit tingkat 3 Baladhika Husada, Jember-Jatim 2006-2008.
Dokter Yonif 408-SBH, Sragen-Jateng 2008-2009.
Dokter Rumkit tingkat 3 Baladhika Husada, Jember-Jatim 2009-2010.
KEANGGOTAAN PROFESI
1. Ikatan Dokter Indonesia (IDI)
2. Perhimpunan Ahli Penyakit Dalam Indonesia (PAPDI)
V.
KURSUS PENATARAN
1. Pelatihan ATLS Jakarta,2004
2. Kursus USG PUSKI Ilmu Penyakit Dalam tahap I. Medan, 2013.
VI.
KARYA ILMIAH
1. Adi S Sembiring, Endang Sembiring, Saut Marpaung, Franciscus Ginting, Tambar
Kembaren, Armon Rahimi, Yosia Ginting. Skrofuloderma pada HIV-AIDS. Kongres
Nasional PETRI XVIII Banda Aceh, 15-16 Juni 2012.
2. Adi S Sembiring, Savita Handayani, Dairion Gatot. Antiphospholipid Syndrome.
KOPAPDI XV Medan, 12-15 Desember 2012.
VII. PARTISIPASI DALAM KEGIATAN ILMIAH
1.
Peserta Seminar Highlights of Important Medical Problems in Daily Practice,
Malang, 3 Juni 2006.
2.
Peserta Kongres Nasional XV Perhimpunan Dokter Spesialis Penyakit Dalam
Indonesia (KOPAPDI XV), Medan, 12-15 Desember 2012.
3.
Peserta Pelatihan Manajemen Nyeri (Diklat Manajemen Nyeri), RSUP H.Adam
Malik Medan, 26 April 2013.
4.
Panitia Simposium Infection Update VI, Medan, 07 September 2013.
5.
Panitia Workshop I (demam), Infection Update VI, Medan, 05 September 2013.
6.
Panitia Workshop II (Sepsis), Infection Update VI, Medan, 06 September 2013.
7.
Peserta Symposium Medan Chest and Clinical Immunology (MCCI), Medan 0507 Desember 2013.
8.
Peserta Workshop Asthma, Medan Chest and Clinical Immunology (MCCI),
Medan 05-07 Desember 2013.
9.
Peserta Workshop Insulin Treatment in Type 2 DM, The Metabolic & Endocrine
Diseases and It’s Analysis-1, Medan, 12-15 February 2014.
10.
Peserta Symposium The Metabolic & Endocrine Diseases and It’s Analysis-1,
Medan, 12-15 February 2014.
11.
Peserta Simposium Life Extention Strategies for Doctor From Basic Sciences to
Clinical Practice, Pertemuan Ilmiah Tahunan XV (PERHOMPEDIN), Medan, 2022 Juni 2014.
Lampiran 7
HASIL STATISTIK
OUTPUT ANALISIS
Frequency Table
Jenis Kelamin
requency
Percent
alid Percent
mulative Percent
ki
61
76,3
76,3
76,3
puan
19
23,8
23,8
100,0
80
100,0
100,0
Asites
requency
Percent
alid Percent
mulative Percent
3
3,8
3,8
3,8
al
24
30,0
30,0
33,8
g
44
55,0
55,0
88,8
9
11,3
11,3
100,0
80
100,0
100,0
Hepatik Ensefalopati
requency
Percent
alid Percent
mulative Percent
f
77
96,3
96,3
96,3
I
1
1,3
1,3
97,5
II
2
2,5
2,5
100,0
80
100,0
100,0
Child Pught
requency
g
Percent
alid Percent
mulative Percent
13
16,3
16,3
16,3
33
41,3
41,3
57,5
34
42,5
42,5
100,0
80
100,0
100,0
Etiologi SH
requency
Percent
alid Percent
mulative Percent
f
33
41,3
41,3
41,3
tis B
43
53,8
53,8
95,0
tis C
3
3,8
3,8
98,8
tis B & C
1
1,3
1,3
100,0
80
100,0
100,0
Ukuran Varises Esofagus
requency
Percent
alid Percent
mulative Percent
30
37,5
37,5
37,5
34
42,5
42,5
80,0
16
20,0
20,0
100,0
80
100,0
100,0
Grup
requency
Percent
alid Percent
mulative Percent
30
37,5
37,5
37,5
50
62,5
62,5
100,0
80
100,0
100,0
Descriptives
Statistic
td. Error
51,33
Confidence Interval for Mean
Bound
48,76
Bound
53,89
mmed Mean
51,03
n
51,00
ce
eviation
132,754
11,522
um
23
mum
88
e
65
uartile Range
15
ness
sis
1,288
,544
,269
1,232
,532
Tests of Normality
a
Kolmogorov-Smirnov
Statistic
df
,071
Shapiro-Wilk
Sig.
80
Statistic
,200
*
df
Sig.
,974
80
,098
is a lower bound of the true significance.
efors Significance Correction
Crosstabs
Case Processing Summary
Cases
Valid
N
Kelamin * Grup
Missing
Percent
N
Total
Percent
N
Percent
80
100,0%
0
0,0%
80
100,0%
* Grup
80
100,0%
0
0,0%
80
100,0%
k Ensefalopati * Grup
80
100,0%
0
0,0%
80
100,0%
Pught * Grup
80
100,0%
0
0,0%
80
100,0%
gi SH * Grup
80
100,0%
0
0,0%
80
100,0%
Jenis Kelamin * Grup
Crosstab
Grup
kecil
Kelamin
ki
besar
Total
22
39
61
22,9
38,1
61,0
hin Jenis Kelamin
36,1%
63,9%
100,0%
hin Grup
73,3%
78,0%
76,3%
8
11
19
7,1
11,9
19,0
hin Jenis Kelamin
42,1%
57,9%
100,0%
hin Grup
26,7%
22,0%
23,8%
30
50
80
30,0
50,0
80,0
37,5%
62,5%
100,0%
100,0%
100,0%
100,0%
ted Count
mpuan
ted Count
ted Count
hin Jenis Kelamin
hin Grup
Chi-Square Tests
Value
on Chi-Square
uity Correction
df
a
1
,635
,041
1
,839
,223
1
,637
,225
b
ood Ratio
mp. Sig. (2-sided) ct Sig. (2-sided)
's Exact Test
-by-Linear Association
alid Cases
,787
,223
1
,637
80
ells (0,0%) have expected count less than 5. The minimum expected count is 7,13.
ct Sig. (1-sided)
,415
mputed only for a 2x2 table
Risk Estimate
5% Confidence Interval
Value
Lower
Upper
Ratio for Jenis Kelamin (lakilaki / perempuan)
,776
,271
2,217
hort Grup = kecil
,857
,459
1,599
hort Grup = besar
1,104
,720
1,693
alid Cases
80
Asites * Grup
Crosstab
Grup
kecil
besar
Total
2
1
3
1,1
1,9
3,0
hin Asites
66,7%
33,3%
100,0%
hin Grup
6,7%
2,0%
3,8%
17
7
24
9,0
15,0
24,0
hin Asites
70,8%
29,2%
100,0%
hin Grup
56,7%
14,0%
30,0%
11
33
44
16,5
27,5
44,0
hin Asites
25,0%
75,0%
100,0%
hin Grup
36,7%
66,0%
55,0%
0
9
9
3,4
5,6
9,0
hin Asites
0,0%
100,0%
100,0%
hin Grup
0,0%
18,0%
11,3%
30
50
80
30,0
50,0
80,0
hin Asites
37,5%
62,5%
100,0%
hin Grup
100,0%
100,0%
100,0%
ted Count
al
ted Count
g
ted Count
ted Count
ted Count
Chi-Square Tests
Value
df
mp. Sig. (2-sided)
a
3
,000
ood Ratio
23,571
3
,000
-by-Linear Association
18,381
1
,000
on Chi-Square
20,800
alid Cases
80
cells (37,5%) have expected count less than 5. The minimum expected
count is 1,13.
Risk Estimate
Value
Ratio for Asites (0 / minimal)
a
k Estimate statistics cannot be computed.
They are only computed for a 2*2 table
without empty cells.
Hepatik Ensefalopati * Grup
Crosstab
Grup
kecil
k Ensefalopati
f
besar
Total
30
47
77
28,9
48,1
77,0
39,0%
61,0%
100,0%
100,0%
94,0%
96,3%
0
1
1
,4
,6
1,0
hin Hepatik Ensefalopati
0,0%
100,0%
100,0%
hin Grup
0,0%
2,0%
1,3%
0
2
2
,8
1,3
2,0
hin Hepatik Ensefalopati
0,0%
100,0%
100,0%
hin Grup
0,0%
4,0%
2,5%
30
50
80
30,0
50,0
80,0
37,5%
62,5%
100,0%
100,0%
100,0%
100,0%
ted Count
hin Hepatik Ensefalopati
hin Grup
I
ted Count
II
ted Count
ted Count
hin Hepatik Ensefalopati
hin Grup
Chi-Square Tests
Value
df
mp. Sig. (2-sided)
a
2
,393
ood Ratio
2,890
2
,236
-by-Linear Association
1,705
1
,192
on Chi-Square
1,870
alid Cases
80
cells (66,7%) have expected count less than 5. The minimum expected
count is ,38.
Risk Estimate
Value
Ratio for Hepatik Ensefalopati
(Negatif / Grade I)
a
k Estimate statistics cannot be computed.
They are only computed for a 2*2 table
without empty cells.
Child Pught * Grup
Crosstab
Grup
kecil
Pught
besar
Total
11
2
13
4,9
8,1
13,0
hin Child Pught
84,6%
15,4%
100,0%
hin Grup
36,7%
4,0%
16,3%
14
19
33
12,4
20,6
33,0
hin Child Pught
42,4%
57,6%
100,0%
hin Grup
46,7%
38,0%
41,3%
5
29
34
12,8
21,3
34,0
hin Child Pught
14,7%
85,3%
100,0%
hin Grup
16,7%
58,0%
42,5%
30
50
80
30,0
50,0
80,0
37,5%
62,5%
100,0%
100,0%
100,0%
100,0%
ted Count
g
ted Count
ted Count
ted Count
hin Child Pught
hin Grup
Chi-Square Tests
Value
df
mp. Sig. (2-sided)
a
2
,000
ood Ratio
21,306
2
,000
-by-Linear Association
19,551
1
,000
on Chi-Square
20,191
alid Cases
80
cells (16,7%) have expected count less than 5. The minimum expected
count is 4,88.
Risk Estimate
Value
Ratio for Child Pught (ringan /
sedang)
a
k Estimate statistics cannot be computed.
They are only computed for a 2*2 table
without empty cells.
Etiologi SH * Grup
Crosstab
Grup
kecil
gi SH
f
besar
Total
18
15
33
12,4
20,6
33,0
hin Etiologi SH
54,5%
45,5%
100,0%
hin Grup
60,0%
30,0%
41,3%
11
32
43
16,1
26,9
43,0
hin Etiologi SH
25,6%
74,4%
100,0%
hin Grup
36,7%
64,0%
53,8%
1
2
3
1,1
1,9
3,0
33,3%
66,7%
100,0%
3,3%
4,0%
3,8%
0
1
1
,4
,6
1,0
hin Etiologi SH
0,0%
100,0%
100,0%
hin Grup
0,0%
2,0%
1,3%
30
50
80
30,0
50,0
80,0
37,5%
62,5%
100,0%
100,0%
100,0%
100,0%
ted Count
tis B
ted Count
tis C
ted Count
hin Etiologi SH
hin Grup
tis B & C
ted Count
ted Count
hin Etiologi SH
hin Grup
Chi-Square Tests
Value
df
mp. Sig. (2-sided)
a
3
,062
ood Ratio
7,654
3
,054
-by-Linear Association
5,894
1
,015
on Chi-Square
7,319
alid Cases
80
cells (50,0%) have expected count less than 5. The minimum expected
count is ,38.
Risk Estimate
Value
Ratio for Etiologi SH (negatif /
Hepatitis B)
a
k Estimate statistics cannot be computed.
They are only computed for a 2*2 table
without empty cells.
Case Processing Summary
Cases
Valid
N
ibu/ul)
in Total (mg/dl)
unit/L)
in (g/L)
etik)
UI/L)
unit/L)
Q
Missing
Percent
N
Total
Percent
N
Percent
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
Descriptives
Statistic
td. Error
51,00
Confidence Interval for Mean
Bound
45,91
Bound
56,09
mmed Mean
50,74
n
51,50
ce
185,517
eviation
13,620
um
23
mum
88
e
65
uartile Range
14
ness
sis
Confidence Interval for Mean
,331
,427
1,033
,833
51,52
1,443
Bound
48,62
Bound
54,42
mmed Mean
51,01
n
50,50
ce
eviation
2,487
104,132
10,205
um
33
mum
85
e
52
uartile Range
15
ness
sis
ibu/ul)
Confidence Interval for Mean
,874
,337
1,184
,662
261,00
29,787
Bound
200,08
Bound
321,92
mmed Mean
247,61
n
224,50
ce
26618,552
eviation
163,152
um
60
mum
715
e
655
uartile Range
238
ness
1,222
,427
sis
1,499
,833
103,96
10,592
Confidence Interval for Mean
Bound
82,68
Bound
125,24
mmed Mean
94,53
n
79,00
ce
eviation
um
5609,223
74,895
23
mum
406
e
383
uartile Range
58
ness
2,295
,337
sis
6,054
,662
4,2427
1,26878
in Total (mg/dl)
Confidence Interval for Mean
Bound
1,6477
Bound
6,8376
mmed Mean
3,2915
n
1,1650
ce
48,294
eviation
6,94938
um
,15
mum
27,55
e
27,40
uartile Range
3,04
ness
2,210
,427
sis
4,303
,833
6,0692
1,09085
Confidence Interval for Mean
Bound
3,8770
Bound
8,2614
mmed Mean
4,9847
n
2,7200
ce
59,498
eviation
7,71349
um
,56
mum
32,18
e
31,62
uartile Range
6,19
ness
2,203
,337
sis
4,554
,662
94,63
20,322
unit/L)
Confidence Interval for Mean
Bound
53,07
Bound
136,20
mmed Mean
80,39
n
52,50
ce
12390,102
eviation
111,311
um
12
mum
489
e
477
uartile Range
73
ness
2,187
,427
sis
4,815
,833
161,26
28,409
Confidence Interval for Mean
mmed Mean
n
ce
Bound
104,17
Bound
218,35
132,19
88,50
40353,584
eviation
200,882
um
18
mum
1075
e
1057
uartile Range
134
ness
2,755
,337
sis
8,911
,662
2,737
,1212
in (g/L)
Confidence Interval for Mean
Bound
2,489
Bound
2,985
mmed Mean
2,676
n
2,700
ce
,441
eviation
,6641
um
1,7
mum
4,9
e
3,2
uartile Range
,6
ness
1,666
,427
sis
4,099
,833
2,342
,0920
Confidence Interval for Mean
Bound
2,157
Bound
2,527
mmed Mean
2,327
n
2,100
ce
,423
eviation
,6506
um
,5
mum
4,0
e
3,5
uartile Range
,9
ness
,226
,337
sis
,854
,662
1,2137
,05788
etik)
Confidence Interval for Mean
Bound
1,0953
Bound
1,3320
mmed Mean
1,2048
n
1,1250
ce
,100
eviation
,31702
um
,55
mum
1,96
e
1,41
uartile Range
,31
ness
,804
,427
sis
,584
,833
1,5110
,06409
Confidence Interval for Mean
mmed Mean
Bound
1,3822
Bound
1,6398
1,4687
n
1,3850
ce
,205
eviation
,45320
um
,89
mum
3,30
e
2,41
uartile Range
,49
ness
1,748
,337
sis
4,267
,662
1,2187
,05904
Confidence Interval for Mean
Bound
1,0979
Bound
1,3394
mmed Mean
1,2109
n
1,1200
ce
,105
eviation
,32337
um
,56
mum
1,91
e
1,35
uartile Range
,32
ness
,842
,427
sis
,412
,833
1,5312
,06300
Confidence Interval for Mean
Bound
1,4046
Bound
1,6578
mmed Mean
1,4858
n
1,3950
ce
,198
eviation
,44544
um
,99
mum
3,33
e
2,34
uartile Range
,48
ness
1,887
,337
sis
4,865
,662
98,70
23,336
UI/L)
Confidence Interval for Mean
Bound
50,97
Bound
146,43
mmed Mean
83,00
n
40,00
ce
16337,321
eviation
127,818
um
6
mum
530
e
524
uartile Range
161
ness
1,927
,427
sis
3,535
,833
179,44
29,603
Confidence Interval for Mean
Bound
119,95
Bound
mmed Mean
238,93
157,39
n
68,00
ce
43817,680
eviation
209,327
um
10
mum
901
e
891
uartile Range
186
ness
1,675
,337
sis
2,111
,662
54,77
12,475
unit/L)
Confidence Interval for Mean
Bound
29,25
Bound
80,28
mmed Mean
45,00
n
26,50
ce
eviation
4668,737
68,328
um
8
mum
346
e
uartile Range
ness
sis
338
48
2,993
,427
11,014
,833
54,54
5,760
Confidence Interval for Mean
Bound
42,96
Bound
66,12
mmed Mean
50,10
n
45,50
ce
1659,070
eviation
40,732
um
9
mum
236
e
227
uartile Range
36
ness
2,262
,337
sis
7,182
,662
1,8832
,18051
Confidence Interval for Mean
Bound
1,5141
Bound
2,2524
mmed Mean
1,7985
n
1,6895
ce
eviation
,977
,98869
um
,53
mum
5,00
e
4,47
uartile Range
1,14
ness
1,423
,427
sis
2,710
,833
2,6404
Confidence Interval for Mean
Bound
2,0769
Bound
3,2039
mmed Mean
2,3844
n
1,9055
ce
,28042
3,932
eviation
1,98287
um
,89
mum
10,14
e
9,26
uartile Range
1,69
ness
2,181
,337
sis
4,884
,662
5,37487
,535786
Q
Confidence Interval for Mean
Bound
4,27906
Bound
6,47067
mmed Mean
5,25819
n
5,52800
ce
eviation
8,612
2,934619
um
1,120
mum
12,606
e
uartile Range
11,486
5,471
ness
,327
,427
-,359
,833
24,45946
2,999681
sis
Confidence Interval for Mean
Bound
18,43138
Bound
30,48754
mmed Mean
21,77569
n
17,49100
ce
449,904
eviation
21,210945
um
7,082
mum
110,424
e
103,342
uartile Range
18,289
ness
2,240
,337
sis
5,508
,662
Tests of Normality
a
Kolmogorov-Smirnov
Statistic
ibu/ul)
in Total (mg/dl)
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
,096
30
,200
*
,979
30
,790
,104
50
,200
*
,956
50
,061
,142
30
,125
,888
30
,004
,233
50
,000
,754
50
,000
,348
30
,000
,621
30
,000
unit/L)
in (g/L)
etik)
UI/L)
unit/L)
Q
is a lower bound of the true significance.
efors Significance Correction
,238
50
,000
,690
50
,000
,275
30
,000
,701
30
,000
,265
50
,000
,664
50
,000
,203
30
,003
,849
30
,001
,165
50
,002
,956
50
,063
,200
30
,003
,902
30
,009
,157
50
,004
,856
50
,000
,219
30
,001
,880
30
,003
,156
50
,004
,837
50
,000
,340
30
,000
,708
30
,000
,277
50
,000
,737
50
,000
,297
30
,000
,624
30
,000
,189
50
,000
,794
50
,000
,165
30
,036
,895
30
,006
,193
50
,000
,738
50
,000
,113
30
,200
*
,959
30
,287
,225
50
,000
,735
50
,000
T-Test
Group Statistics
N
Mean
Std. Deviation
td. Error Mean
30
51,00
13,620
2,487
50
51,52
10,205
1,443
Independent Samples Test
vene's Test for
Equality of
Variances
F
variances
assumed
variances
not
assumed
Sig.
1,703
t-test for Equality of Means
t
,196
Confidence Interval of
the Difference
Mean
Differen
2-tailed)
ce Error Difference ower
Upper
df
-,194
78
,846
-,520
2,677
-5,850
4,810
-,181
48,563
,857
-,520
2,875
-6,299
5,259
ROC Curve
Notes
t Created
20-JUN-2015 13:16:13
ments
OJECT\STATISTIK\PENY
DALAM\ADI\data dasar dr Adi.sav
Dataset
et1
>
t
>
ile
>
ows in Working Data File
g Value Handling
ion of Missing
80
defined missing values are treated as
missing.
Used
ics are based on all cases with valid data
for all variables in the analysis.
x
FibroQ BY katGroup (1)
T=CURVE(REFERENCE)
NT=SE COORDINATES
TERIA=CUTOFF(INCLUDE)
TESTPOS(LARGE)
DISTRIBUTION(FREE) CI(95)
SING=EXCLUDE.
rces
ssor Time
00:00:00,33
ed Time
00:00:00,33
Case Processing Summary
n Varises Esofagus
lid N (listwise)
a
50
ve
30
ve
r values of the test result variable(s) indicate
stronger evidence for a positive actual state.
positive actual state is besar.
Area Under the Curve
Test Result Variable(s): FibroQ
symptotic 95% Confidence Interval
Area
td. Error
,963
a
ymptotic Sig.
,018
der the nonparametric assumption
hypothesis: true area = 0.5
b
Lower Bound
,000
Upper Bound
,928
,997
Coordinates of the Curve
Test Result Variable(s): FibroQ
ive if Greater Than or
Equal To
a
Sensitivity
1 - Specificity
,12000
1,000
1,000
1,14400
1,000
,967
1,39950
1,000
,933
1,66200
1,000
,900
1,78050
1,000
,867
1,87400
1,000
,833
1,96400
1,000
,800
2,21250
1,000
,767
3,01950
1,000
,733
3,67050
1,000
,700
3,96900
1,000
,667
4,32700
1,000
,633
4,54400
1,000
,600
4,73150
1,000
,567
5,12450
1,000
,533
5,52800
1,000
,500
5,64800
1,000
,467
5,95800
1,000
,433
6,22750
1,000
,400
6,47250
1,000
,367
6,72550
1,000
,333
6,92300
1,000
,300
7,09700
,980
,300
7,12100
,960
,300
7,13100
,940
,300
7,40000
,940
,267
7,69100
,920
,267
7,81700
,920
,233
7,99050
,920
,200
8,25200
,920
,167
8,49550
,920
,133
8,54850
,900
,133
8,56050
,900
,100
8,58850
,880
,100
8,78600
,860
,100
8,97900
,860
,067
9,14050
,840
,067
9,61000
,820
,067
9,94000
,820
,033
10,07950
,800
,033
10,55700
,780
,033
10,94050
,760
,033
11,15600
,740
,033
11,43150
,720
,033
11,53700
,700
,033
12,07650
,680
,033
12,80750
,680
,000
13,03250
,660
,000
13,41650
,640
,000
13,89750
,620
,000
14,59600
,600
,000
15,75250
,580
,000
16,66450
,560
,000
17,15950
,540
,000
17,34800
,520
,000
17,49100
,500
,000
17,69800
,480
,000
17,86300
,460
,000
18,13200
,440
,000
18,85700
,420
,000
19,41350
,400
,000
19,67950
,380
,000
21,75600
,360
,000
23,95800
,340
,000
24,71050
,320
,000
25,68600
,300
,000
27,64250
,280
,000
29,02200
,260
,000
29,46050
,240
,000
31,73000
,220
,000
34,21600
,200
,000
34,94200
,180
,000
36,00950
,160
,000
37,92350
,140
,000
43,85350
,120
,000
52,75050
,100
,000
63,55700
,080
,000
73,49400
,060
,000
76,57200
,040
,000
93,52400
,020
,000
111,42400
,000
,000
smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the maximum
observed test value plus 1. All the other cutoff values are the averages of two consecutive ordered observed
test values.
katFQ * KG2 Crosstabulation
KG2
besar
hin KG2
6
hin KG2
hin KG2
kecil
Total
45
3
48
90,0%
10,0%
60,0%
5
27
32
10,0%
90,0%
40,0%
50
30
80
100,0%
100,0%
100,0%
Data Hasil
Penelitian
Lampiran 6
No
Nama
Umur
L/P
MR
Plt.(10/L)
Bil. Total
AST
Albumin
1
Aman Sidabutar
52
1
586933
57
1,2
44
2,4
2
Arifin Silitonga
52
1
596253
342
0,65
18
3,1
3
Enda Malam
40
2
593761
23
2,11
61
1,6
4
Johanis T
45
1
593411
36
4,71
120
1,6
5
Momen
54
1
5946S4
89
1,36
62
2
6
Netti
47
2
588439
60
9,83
1075
2,9
7
Paristono
58
1
589213
72
2,53
200
2,9
8
Sehat Purba
40
1
587426
138
5,43
367
3,1
9
Sofi Yusrizal
36
2
595655
102
0,36
23
2,3
10
Sukiman
48
1
592770
62
7,31
166
2,1
11
Syafiah
53
1
590663
90
0,98
41
2
12
Erisa br Siahaan
58
2
620072
33
0,62
18
2
13
Hedwar Sibarani
49
1
559465
70
5,13
88
2,1
14
Herman
41
1
613573
83
2,11
155
2,5
15
Irianto
61
1
410716
94
4,66
142
2,7
16
Jimmy Panjaitan
36
1
548819
66
2,66
47
1,9
17
Joni Indra
43
1
621147
73
14,96
526
3,8
18
Juandy Marpaung
33
1
605427
433
0,73
15
4,5
19
Kasume Tambunan
53
1
600820
61
0,78
82
2,6
20
M.Syahni
41
1
602903
44
1,25
22
2,2
21
Tetap
52
1
606204
363
8,8
111
2,9
22
Abd Thalib
57
1
577673
184
0,3
20
4,9
23
Ahmad Kasrun
52
1
555770
118
27,57
125
1,6
24
Andi Ramadani
23
1
582156
266
16,9
320
2
25
Apul Sidabutar
61
1
5438?8
190
3,91
731
2
26
Arifin
41
1
570102
120
1,3
35
2
27
Aripin Bancin
43
1
620310
112
2,02
176
3,1
28
Armen Sembiring
53
1
548865
87
1,49
36
1,5
29
Asmara Sitompul
72
1
617861
207
10,63
175
2,6
30
Marulak Nadeak
50
1
612247
68
7,63
343
2,1
31
Baini
51
1
555380
65
0,68
29
2,7
32
Bun Ngials
54
1
623008
121
2,17
33
1,7
33
Darmadi Hutagaol
43
1
604612
108
11,26
175
2,1
34
Daud Simarmata
53
1
618951
139
3,58
40
1,7
35
Dedi Tarigan
46
1
585645
75
20,34
100
1,6
36
Mariono Lesmana
44
1
605782
135
0,43
12
2,7
37
Misbah Udin
42
1
611412
180
1,19
50
0,5
38
Nisma Siregar
55
2
597747
154
0,25
31
2,8
39
Nurmansyah
38
1
602557
204
1,37
284
3,4
40
Ponimin
39
1
610014
46
0,89
42
2,9
41
Rasyad Lubis
65
1
609517
406
31,64
506
2,1
42
Kantin Barus
49
2
622248
386
27,55
217
2,9
43
Koko Saputra
48
1
627279
111
6,04
94
2,9
44
Krisna
40
1
617442
60
8,6
53
2,2
45
Lisria Sitanggang
51
2
614437
117
2,78
123
1,9
46
Lidia Siahaan
72
2
594014
674
0,38
47
3,1
47
Mestiana sinurat
41
2
622241
73
0,9
76
2
48
Roshidawati S
48
2
622854
70
7,35
179
2,5
49
Rusli Sitepu
58
1
625504
126
6,18
89
2,1
50
Salomo Sitepu
49
1
614686
187
1,29
67
2,5
51
Sanimin
64
1
620531
68
11,92
128
1,5
52
Selamat saragih
72
1
624881
134
1,13
75
2,4
53
Sri Wondo
54
2
620866
135
2,47
84
1,8
54
Wasina
55
2
625334
245
0,78
43
2,3
55
Aliaman Tambunan
62
1
628170
258
2,79
52
2,8
56
Ngatiah
57
2
547023
271
1,11
92
2,9
57
Suhery
44
1
511721
199
1,19
68
2,7
58
Ardiansyah
26
1
553523
431
1,14
110
2,9
59
Oberlin
46
1
941908
35
2,26
35
2,9
60
Wagini
88
2
618409
261
14,97
267
2,4
61
M.saleh
57
1
630138
79
0,73
40
2,1
62
Uparis simamora
60
1
459933
78
0,56
62
3,7
63
Sirus muthe
61
1
612826
112
1,31
18
2,4
64
Sarachsi
69
1
629841
59
2,51
124
2,5
65
Soden ginting
70
1
631722
79
3,22
110
2,8
66
Parlindungan S
46
1
632846
343
0,28
23
2,5
67
Wilson S
57
1
593013
715
21,17
93
2
68
Z.Bukhari
59
1
608665
404
0,15
26
2,3
69
Naimah nuri P
63
2
504960
53
0,89
35
2,9
70
Zunaidah
49
2
615783
39
3,94
69
2
71
Toguan
45
1
628699
389
2,82
489
3,1
72
Sudarto
46
1
588844
87
0,8
18
4
73
Hotmaida
42
2
619717
72
8,97
38
2,1
74
Arifin Nasution
52
1
597758
93
1,24
19
2,9
75
Arjuna Tarigan
57
1
553344
249
17,9
306
2,3
76
Edi Susanto
45
1
564224
340
32,18
491
2,1
77
Maria
64
2
600631
161
0,64
74
2,8
78
Katiman
85
1
618126
132
2,25
35
2,9
79
Nuzul Indra
33
1
624720
240
3,46
241
3,1
80
Rohana
48
2
620214
87
1,17
46
2,8
Keterangan :
*) Jenis Kelamin
*) Asites
*) CP (Child Pugh)
Laki-laki
=1
Tidak ada Asites
Perempuan
=2
Asites minimal
=1
B (Sedang)
Asites sedang
=2
C (Berat)
Asites berat
=3
*) Hepatic Encephalopathy
(HE)
=0
A (Ringan)
*) Etiologi SH
Tidak ada HE
=0
Bukan Hep.B&C
HE grade 1
=1
Hep.B
HE grade 2
=2
Hep.C
Hep.B&C
INR
Asites
HE
CP
Etio.SH
ø VE
Grup ø
ALT
FibroQ
1,58
2
0
3
0
2
2
9
70,468
0,99
1
0
1
0
1
1
16
1,693
1,75
3
1
3
1
2
2
38
48,855
1,58
3
0
3
1
2
2
61
38,852
1,34
2
0
2
1
3
2
26
19,387
1,39
2
0
3
0
2
2
106
110,424
1,24
2
0
2
1
3
2
54
36,995
1,5
3
0
3
1
2
2
55
29,011
1,08
1
0
1
0
1
1
16
5,479
1,74
1
0
3
1
2
2
127
17,607
1,48
2
0
3
1
2
2
31
11,527
1,19
2
0
2
2
3
2
15
25,098
2,09
2
0
3
0
2
2
49
26,274
1,09
2
0
2
1
3
2
55
15,174
2,11
2
0
3
1
3
2
100
19,44
1,72
2
2
3
0
2
2
27
16,331
1,63
2
0
3
1
2
2
66
76,52
1,47
1
0
1
0
1
1
15
1,12
1,72
2
0
3
3
2
2
41
29,888
1,4
1
0
2
0
3
2
16
17,937
1,14
2
0
3
1
1
1
38
4,77
1,1
1
0
1
0
1
1
16
4,259
3,33
2
0
3
0
3
2
141
13,009
1,8
2
0
3
0
1
1
136
3,662
1,14
2
0
3
1
2
2
236
11,336
1,1
2
0
2
1
1
1
23
5,719
1,26
2
0
2
1
2
2
49
17,375
1,35
3
0
2
0
2
2
29
10,209
1,16
2
0
3
2
2
2
76
9,29
0,99
2
0
3
1
3
2
86
29,033
1,1
1
0
2
0
1
1
37
6,764
1,04
2
0
3
1
1
1
19
8,061
1,92
1
0
2
1
2
2
55
24,323
1,59
2
0
3
0
2
2
21
11,547
2,17
3
0
3
1
3
2
38
35,024
0,96
1
0
1
0
1
1
8
4,693
1,45
3
0
3
1
2
2
17
9,95
0,93
2
0
2
0
1
1
13
7,92
1,23
1
0
1
1
1
1
105
6,197
0,99
2
0
2
1
3
2
27
13,056
1,28
2
0
3
1
2
2
61
16,998
0,56
2
0
3
0
1
1
132
1,168
0,93
1
0
2
1
1
1
49
7,714
1,04
1
0
3
0
1
1
37
9,93
2,1
2
0
3
1
2
2
65
17,321
1,02
2
0
2
0
1
1
25
2,048
1,26
1
2
3
1
2
2
49
10,976
1,73
3
0
3
1
3
2
90
23,593
1,7
3
0
3
1
3
2
38
18,327
1
1
0
2
0
1
1
35
5,577
2,21
2
0
3
1
2
2
47
56,646
1,32
1
0
2
2
1
1
85
6,258
1,85
1
0
3
1
2
2
57
10,905
1,86
1
0
2
1
1
1
21
8,549
1,22
1
0
2
0
1
1
17
8,967
0,96
1
0
1
1
1
1
22
8,443
1,4
1
0
2
1
1
1
129
1,631
1,22
1
0
1
1
1
1
22
3,679
1,44
1
0
2
1
2
2
19
34,86
1,03
2
0
2
0
1
1
130
7,132
1,36
2
0
2
1
2
2
28
14,018
1,3
2
0
1
0
2
2
45
13,777
1,91
2
0
2
1
1
1
28
6,687
1,12
2
0
2
0
2
2
65
19,919
1,24
2
0
2
1
2
2
36
33,572
1,71
0
0
1
0
1
1
12
4,395
1,86
2
0
2
0
1
1
58
2,377
1,23
0
0
1
0
1
1
25
1,868
1,24
2
0
1
1
2
2
29
17,789
2,74
0
0
2
0
2
2
31
76,624
1,15
2
0
2
1
1
1
346
1,88
1,2
1
0
2
1
3
2
16
7,13
1,28
2
0
3
0
3
2
37
7,668
1,4
2
0
2
0
3
2
21
7,082
1,29
3
0
3
1
2
2
105
8,605
1,39
2
0
3
1
2
2
127
7,112
1,2
1
0
1
0
1
1
28
12,606
1,1
2
0
2
0
2
2
29
8,548
1,19
2
0
2
1
2
2
46
8,572
1,24
2
0
2
0
3
2
35
8,991
*) ø
Varices Esophagus)
=1
F1
=
1
=2
F2
=
2
=3
F3
=
3
VE (Varices
esipagus)
*) Grup ø
=0
Kecil
=
1
=1
Besar
=
2
=2
=3
Lampiran 2
LEMBAR PENJELASAN KEPADA CALON SUBJEK PENELITIAN
Assalamualaikum wr.Wb.
Salam sejahtera bagi Bapak/Ibu, Saudara/i,
Terima kasih atas kesediaan Bapak/Ibu, Saudara/i, meluangkan waktu untuk
membaca dan mengisi surat persetujuan ini. Sebelumnya, perkenankan saya
memperkenalkan diri. Nama saya dr. Adi Sumanta Sembiring G, peserta
Program Pendidikan Dokter Spesialis Ilmu Penyakit Dalam di Fakultas
Kedokteran Universitas Sumatera Utara (FK-USU). Saya sedang melakukan
pengumpulan data penelitian tugas akhir sebagai salah satu syarat
menyelesaikan pendidikan di FK-USU. Adapun judul penelitian saya adalah
“Hubungan Besar Varises Esofagus Secara Endoskopi Dengan INDEKS
FIBROQ Pada Penderita Sirosis hati.”
Penelitian ini bertujuan untuk mengetahui hubungan antara besar varises esofagus
secara endoskopi dengan INDEKS FIBROQ pada penderita sirosis hati dan untuk
melihat akurasi INDEKS FIBROQ dalam memprediksi ukuran varises esofagus
dengan endoskopi pada pasien sirosis hati.
Kepada bapak/ibu yang bersedia mengikuti penelitian ini nantinya akan
diminta mengisi surat persetujuan ikut dalam penelitian, mengikuti
wawancara dan menjalani pemeriksaan fisik.
Perlu saya ingatkan, keikutsertaan Bapak/Ibu, Saudara/i adalah sukarela dan
tidak dikenakan biaya. Semua data yang terkumpul saya jamin
kerahasiaannya. Bila keterangan yang saya berikan masih belum jelas,
Bapak/Ibu, Saudara/I dapat menanyakan langsung kepada saya :
Nama
: dr. Adi Sumanta Sembiring G
Alamat
: Jl. Bunga Ester Komp.Mobil Oil no.91D Medan
No.telp
: 085362129478
Atas perhatian Bapak/Ibu, Saudara/I saya ucapkan terima kasih.
Hormat saya,
dr.Adi Sumanta Sembiring G
Lampiran 3
SURAT PERSETUJUAN SETELAH PENJELASAN
(INFORMED CONSENT )
Saya yang bertanda tangan dibawah ini :
Nama
:...........................................................................................
Alamat
:...........................................................................................
Umur
:........................ Tahun
Jenis Kelamin : Laki-laki/ Perempuan*
No Telp/ HP
:
Setelah mendapat penjelasan dari peneliti tentang kebaikan dan keburukan
prosedur penelitian ini, menyatakan BERSEDIA ikut serta dalam penelitian
tentang ”Hubungan Besar Varises Esofagus Secara Endoskopi dengan
indeks FibroQ pada Penderita Sirosis Hati”. Apabila sewaktu-waktu saya
mengundurkan diri dari penelitian ini, kepada saya tidak dituntut apapun.
Demikianlah surat persetujuan bersedia ikut dalam penelitian ini saya buat, untuk
dapat digunakan seperlunya.
Medan, ...........................2014
Yang
pernyataan,
(................................)
*Coret yang tidak perlu
memberi
Lampiran 4
KERTAS KERJA PROFIL PESERTA PENELITIAN
DATA PESERTA
Tanggal:
MR
:
No. Peserta
:
I. IDENTITAS PRIBADI
Nama
:
Tempat/ Tanggal lahir/Usia
:
Jenis kelamin
: Laki-laki / Perempuan
Pendidikan terakhir
:
Pekerjaan
:
Status
Telp................
:
Faktor risiko
:
No. Telp/Hp
:
Kawin
/
Belum
II. PEMERIKSAAN FISIK
III. PEMERIKSAAN LABORATORIUM
Parameter
Trombosit (sel/mm3)
AST (U/L)
ALT (U/L)
INR
Nilai
Kawin.
No
IV. PEMERIKSAAN PENUNJANG.
Hasil USG Abdomen:
Hasil Endoskopi:
V. Indeks FIBROQ:
LAMPIRAN 5
DAFTAR RIWAYAT HIDUP
I.
DATA PRIBADI
Nama
Tempat/Tgl.lahir
Jenis kelamin
Agama
Pekerjaan
NRP
Pangkat/Gol.
Istri
Anak
Alamat pekerjaan
Alamat rumah
Telepon selular
II.
:
:
:
:
:
:
:
:
:
dr. Adi Sumanta Sembiring G
Binjai/ 02 Juli 1979
Laki-laki
Islam
Dokter/TNI
11040008960779
Kapten
Sri Rezekika Maulida, SS
M. Harun Adly S
Ahmad Lukman Adly S
Chairina Arsyifa Adly
: Direktorat Kesehatan Angkatan Darat,
Markas Besar Angkatan Darat, Jakarta
: Jl. Bunga Ester komp.Mobil Oil No.91 D Medan
20131
: 085362129478
PENDIDIKAN
1. SD Advent 4 (1985-1991) di Medan, Kotamadya Medan - Sumatera Utara
2. SMP Negeri 1 Medan (1991-1994) di Medan - Sumatera Utara
3. SMU PKMI 1 Medan(1994-1997) di Medan - Sumatera Utara
4. Fakultas Kedokteran Universitas Sumatera Utara (1997-2003) di Medan - Sumatera
Utara.
5. PPDS Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Sumatera Utara (2010sekarang) di Medan-Sumatera Utara
III.
RIWAYAT PEKERJAAN
1.
2.
3.
4.
IV.
Dokter Yonkav 3/Tank, Malang-Jatim 2004-2006.
Dokter Rumkit tingkat 3 Baladhika Husada, Jember-Jatim 2006-2008.
Dokter Yonif 408-SBH, Sragen-Jateng 2008-2009.
Dokter Rumkit tingkat 3 Baladhika Husada, Jember-Jatim 2009-2010.
KEANGGOTAAN PROFESI
1. Ikatan Dokter Indonesia (IDI)
2. Perhimpunan Ahli Penyakit Dalam Indonesia (PAPDI)
V.
KURSUS PENATARAN
1. Pelatihan ATLS Jakarta,2004
2. Kursus USG PUSKI Ilmu Penyakit Dalam tahap I. Medan, 2013.
VI.
KARYA ILMIAH
1. Adi S Sembiring, Endang Sembiring, Saut Marpaung, Franciscus Ginting, Tambar
Kembaren, Armon Rahimi, Yosia Ginting. Skrofuloderma pada HIV-AIDS. Kongres
Nasional PETRI XVIII Banda Aceh, 15-16 Juni 2012.
2. Adi S Sembiring, Savita Handayani, Dairion Gatot. Antiphospholipid Syndrome.
KOPAPDI XV Medan, 12-15 Desember 2012.
VII. PARTISIPASI DALAM KEGIATAN ILMIAH
1.
Peserta Seminar Highlights of Important Medical Problems in Daily Practice,
Malang, 3 Juni 2006.
2.
Peserta Kongres Nasional XV Perhimpunan Dokter Spesialis Penyakit Dalam
Indonesia (KOPAPDI XV), Medan, 12-15 Desember 2012.
3.
Peserta Pelatihan Manajemen Nyeri (Diklat Manajemen Nyeri), RSUP H.Adam
Malik Medan, 26 April 2013.
4.
Panitia Simposium Infection Update VI, Medan, 07 September 2013.
5.
Panitia Workshop I (demam), Infection Update VI, Medan, 05 September 2013.
6.
Panitia Workshop II (Sepsis), Infection Update VI, Medan, 06 September 2013.
7.
Peserta Symposium Medan Chest and Clinical Immunology (MCCI), Medan 0507 Desember 2013.
8.
Peserta Workshop Asthma, Medan Chest and Clinical Immunology (MCCI),
Medan 05-07 Desember 2013.
9.
Peserta Workshop Insulin Treatment in Type 2 DM, The Metabolic & Endocrine
Diseases and It’s Analysis-1, Medan, 12-15 February 2014.
10.
Peserta Symposium The Metabolic & Endocrine Diseases and It’s Analysis-1,
Medan, 12-15 February 2014.
11.
Peserta Simposium Life Extention Strategies for Doctor From Basic Sciences to
Clinical Practice, Pertemuan Ilmiah Tahunan XV (PERHOMPEDIN), Medan, 2022 Juni 2014.
Lampiran 7
HASIL STATISTIK
OUTPUT ANALISIS
Frequency Table
Jenis Kelamin
requency
Percent
alid Percent
mulative Percent
ki
61
76,3
76,3
76,3
puan
19
23,8
23,8
100,0
80
100,0
100,0
Asites
requency
Percent
alid Percent
mulative Percent
3
3,8
3,8
3,8
al
24
30,0
30,0
33,8
g
44
55,0
55,0
88,8
9
11,3
11,3
100,0
80
100,0
100,0
Hepatik Ensefalopati
requency
Percent
alid Percent
mulative Percent
f
77
96,3
96,3
96,3
I
1
1,3
1,3
97,5
II
2
2,5
2,5
100,0
80
100,0
100,0
Child Pught
requency
g
Percent
alid Percent
mulative Percent
13
16,3
16,3
16,3
33
41,3
41,3
57,5
34
42,5
42,5
100,0
80
100,0
100,0
Etiologi SH
requency
Percent
alid Percent
mulative Percent
f
33
41,3
41,3
41,3
tis B
43
53,8
53,8
95,0
tis C
3
3,8
3,8
98,8
tis B & C
1
1,3
1,3
100,0
80
100,0
100,0
Ukuran Varises Esofagus
requency
Percent
alid Percent
mulative Percent
30
37,5
37,5
37,5
34
42,5
42,5
80,0
16
20,0
20,0
100,0
80
100,0
100,0
Grup
requency
Percent
alid Percent
mulative Percent
30
37,5
37,5
37,5
50
62,5
62,5
100,0
80
100,0
100,0
Descriptives
Statistic
td. Error
51,33
Confidence Interval for Mean
Bound
48,76
Bound
53,89
mmed Mean
51,03
n
51,00
ce
eviation
132,754
11,522
um
23
mum
88
e
65
uartile Range
15
ness
sis
1,288
,544
,269
1,232
,532
Tests of Normality
a
Kolmogorov-Smirnov
Statistic
df
,071
Shapiro-Wilk
Sig.
80
Statistic
,200
*
df
Sig.
,974
80
,098
is a lower bound of the true significance.
efors Significance Correction
Crosstabs
Case Processing Summary
Cases
Valid
N
Kelamin * Grup
Missing
Percent
N
Total
Percent
N
Percent
80
100,0%
0
0,0%
80
100,0%
* Grup
80
100,0%
0
0,0%
80
100,0%
k Ensefalopati * Grup
80
100,0%
0
0,0%
80
100,0%
Pught * Grup
80
100,0%
0
0,0%
80
100,0%
gi SH * Grup
80
100,0%
0
0,0%
80
100,0%
Jenis Kelamin * Grup
Crosstab
Grup
kecil
Kelamin
ki
besar
Total
22
39
61
22,9
38,1
61,0
hin Jenis Kelamin
36,1%
63,9%
100,0%
hin Grup
73,3%
78,0%
76,3%
8
11
19
7,1
11,9
19,0
hin Jenis Kelamin
42,1%
57,9%
100,0%
hin Grup
26,7%
22,0%
23,8%
30
50
80
30,0
50,0
80,0
37,5%
62,5%
100,0%
100,0%
100,0%
100,0%
ted Count
mpuan
ted Count
ted Count
hin Jenis Kelamin
hin Grup
Chi-Square Tests
Value
on Chi-Square
uity Correction
df
a
1
,635
,041
1
,839
,223
1
,637
,225
b
ood Ratio
mp. Sig. (2-sided) ct Sig. (2-sided)
's Exact Test
-by-Linear Association
alid Cases
,787
,223
1
,637
80
ells (0,0%) have expected count less than 5. The minimum expected count is 7,13.
ct Sig. (1-sided)
,415
mputed only for a 2x2 table
Risk Estimate
5% Confidence Interval
Value
Lower
Upper
Ratio for Jenis Kelamin (lakilaki / perempuan)
,776
,271
2,217
hort Grup = kecil
,857
,459
1,599
hort Grup = besar
1,104
,720
1,693
alid Cases
80
Asites * Grup
Crosstab
Grup
kecil
besar
Total
2
1
3
1,1
1,9
3,0
hin Asites
66,7%
33,3%
100,0%
hin Grup
6,7%
2,0%
3,8%
17
7
24
9,0
15,0
24,0
hin Asites
70,8%
29,2%
100,0%
hin Grup
56,7%
14,0%
30,0%
11
33
44
16,5
27,5
44,0
hin Asites
25,0%
75,0%
100,0%
hin Grup
36,7%
66,0%
55,0%
0
9
9
3,4
5,6
9,0
hin Asites
0,0%
100,0%
100,0%
hin Grup
0,0%
18,0%
11,3%
30
50
80
30,0
50,0
80,0
hin Asites
37,5%
62,5%
100,0%
hin Grup
100,0%
100,0%
100,0%
ted Count
al
ted Count
g
ted Count
ted Count
ted Count
Chi-Square Tests
Value
df
mp. Sig. (2-sided)
a
3
,000
ood Ratio
23,571
3
,000
-by-Linear Association
18,381
1
,000
on Chi-Square
20,800
alid Cases
80
cells (37,5%) have expected count less than 5. The minimum expected
count is 1,13.
Risk Estimate
Value
Ratio for Asites (0 / minimal)
a
k Estimate statistics cannot be computed.
They are only computed for a 2*2 table
without empty cells.
Hepatik Ensefalopati * Grup
Crosstab
Grup
kecil
k Ensefalopati
f
besar
Total
30
47
77
28,9
48,1
77,0
39,0%
61,0%
100,0%
100,0%
94,0%
96,3%
0
1
1
,4
,6
1,0
hin Hepatik Ensefalopati
0,0%
100,0%
100,0%
hin Grup
0,0%
2,0%
1,3%
0
2
2
,8
1,3
2,0
hin Hepatik Ensefalopati
0,0%
100,0%
100,0%
hin Grup
0,0%
4,0%
2,5%
30
50
80
30,0
50,0
80,0
37,5%
62,5%
100,0%
100,0%
100,0%
100,0%
ted Count
hin Hepatik Ensefalopati
hin Grup
I
ted Count
II
ted Count
ted Count
hin Hepatik Ensefalopati
hin Grup
Chi-Square Tests
Value
df
mp. Sig. (2-sided)
a
2
,393
ood Ratio
2,890
2
,236
-by-Linear Association
1,705
1
,192
on Chi-Square
1,870
alid Cases
80
cells (66,7%) have expected count less than 5. The minimum expected
count is ,38.
Risk Estimate
Value
Ratio for Hepatik Ensefalopati
(Negatif / Grade I)
a
k Estimate statistics cannot be computed.
They are only computed for a 2*2 table
without empty cells.
Child Pught * Grup
Crosstab
Grup
kecil
Pught
besar
Total
11
2
13
4,9
8,1
13,0
hin Child Pught
84,6%
15,4%
100,0%
hin Grup
36,7%
4,0%
16,3%
14
19
33
12,4
20,6
33,0
hin Child Pught
42,4%
57,6%
100,0%
hin Grup
46,7%
38,0%
41,3%
5
29
34
12,8
21,3
34,0
hin Child Pught
14,7%
85,3%
100,0%
hin Grup
16,7%
58,0%
42,5%
30
50
80
30,0
50,0
80,0
37,5%
62,5%
100,0%
100,0%
100,0%
100,0%
ted Count
g
ted Count
ted Count
ted Count
hin Child Pught
hin Grup
Chi-Square Tests
Value
df
mp. Sig. (2-sided)
a
2
,000
ood Ratio
21,306
2
,000
-by-Linear Association
19,551
1
,000
on Chi-Square
20,191
alid Cases
80
cells (16,7%) have expected count less than 5. The minimum expected
count is 4,88.
Risk Estimate
Value
Ratio for Child Pught (ringan /
sedang)
a
k Estimate statistics cannot be computed.
They are only computed for a 2*2 table
without empty cells.
Etiologi SH * Grup
Crosstab
Grup
kecil
gi SH
f
besar
Total
18
15
33
12,4
20,6
33,0
hin Etiologi SH
54,5%
45,5%
100,0%
hin Grup
60,0%
30,0%
41,3%
11
32
43
16,1
26,9
43,0
hin Etiologi SH
25,6%
74,4%
100,0%
hin Grup
36,7%
64,0%
53,8%
1
2
3
1,1
1,9
3,0
33,3%
66,7%
100,0%
3,3%
4,0%
3,8%
0
1
1
,4
,6
1,0
hin Etiologi SH
0,0%
100,0%
100,0%
hin Grup
0,0%
2,0%
1,3%
30
50
80
30,0
50,0
80,0
37,5%
62,5%
100,0%
100,0%
100,0%
100,0%
ted Count
tis B
ted Count
tis C
ted Count
hin Etiologi SH
hin Grup
tis B & C
ted Count
ted Count
hin Etiologi SH
hin Grup
Chi-Square Tests
Value
df
mp. Sig. (2-sided)
a
3
,062
ood Ratio
7,654
3
,054
-by-Linear Association
5,894
1
,015
on Chi-Square
7,319
alid Cases
80
cells (50,0%) have expected count less than 5. The minimum expected
count is ,38.
Risk Estimate
Value
Ratio for Etiologi SH (negatif /
Hepatitis B)
a
k Estimate statistics cannot be computed.
They are only computed for a 2*2 table
without empty cells.
Case Processing Summary
Cases
Valid
N
ibu/ul)
in Total (mg/dl)
unit/L)
in (g/L)
etik)
UI/L)
unit/L)
Q
Missing
Percent
N
Total
Percent
N
Percent
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
30
100,0%
0
0,0%
30
100,0%
50
100,0%
0
0,0%
50
100,0%
Descriptives
Statistic
td. Error
51,00
Confidence Interval for Mean
Bound
45,91
Bound
56,09
mmed Mean
50,74
n
51,50
ce
185,517
eviation
13,620
um
23
mum
88
e
65
uartile Range
14
ness
sis
Confidence Interval for Mean
,331
,427
1,033
,833
51,52
1,443
Bound
48,62
Bound
54,42
mmed Mean
51,01
n
50,50
ce
eviation
2,487
104,132
10,205
um
33
mum
85
e
52
uartile Range
15
ness
sis
ibu/ul)
Confidence Interval for Mean
,874
,337
1,184
,662
261,00
29,787
Bound
200,08
Bound
321,92
mmed Mean
247,61
n
224,50
ce
26618,552
eviation
163,152
um
60
mum
715
e
655
uartile Range
238
ness
1,222
,427
sis
1,499
,833
103,96
10,592
Confidence Interval for Mean
Bound
82,68
Bound
125,24
mmed Mean
94,53
n
79,00
ce
eviation
um
5609,223
74,895
23
mum
406
e
383
uartile Range
58
ness
2,295
,337
sis
6,054
,662
4,2427
1,26878
in Total (mg/dl)
Confidence Interval for Mean
Bound
1,6477
Bound
6,8376
mmed Mean
3,2915
n
1,1650
ce
48,294
eviation
6,94938
um
,15
mum
27,55
e
27,40
uartile Range
3,04
ness
2,210
,427
sis
4,303
,833
6,0692
1,09085
Confidence Interval for Mean
Bound
3,8770
Bound
8,2614
mmed Mean
4,9847
n
2,7200
ce
59,498
eviation
7,71349
um
,56
mum
32,18
e
31,62
uartile Range
6,19
ness
2,203
,337
sis
4,554
,662
94,63
20,322
unit/L)
Confidence Interval for Mean
Bound
53,07
Bound
136,20
mmed Mean
80,39
n
52,50
ce
12390,102
eviation
111,311
um
12
mum
489
e
477
uartile Range
73
ness
2,187
,427
sis
4,815
,833
161,26
28,409
Confidence Interval for Mean
mmed Mean
n
ce
Bound
104,17
Bound
218,35
132,19
88,50
40353,584
eviation
200,882
um
18
mum
1075
e
1057
uartile Range
134
ness
2,755
,337
sis
8,911
,662
2,737
,1212
in (g/L)
Confidence Interval for Mean
Bound
2,489
Bound
2,985
mmed Mean
2,676
n
2,700
ce
,441
eviation
,6641
um
1,7
mum
4,9
e
3,2
uartile Range
,6
ness
1,666
,427
sis
4,099
,833
2,342
,0920
Confidence Interval for Mean
Bound
2,157
Bound
2,527
mmed Mean
2,327
n
2,100
ce
,423
eviation
,6506
um
,5
mum
4,0
e
3,5
uartile Range
,9
ness
,226
,337
sis
,854
,662
1,2137
,05788
etik)
Confidence Interval for Mean
Bound
1,0953
Bound
1,3320
mmed Mean
1,2048
n
1,1250
ce
,100
eviation
,31702
um
,55
mum
1,96
e
1,41
uartile Range
,31
ness
,804
,427
sis
,584
,833
1,5110
,06409
Confidence Interval for Mean
mmed Mean
Bound
1,3822
Bound
1,6398
1,4687
n
1,3850
ce
,205
eviation
,45320
um
,89
mum
3,30
e
2,41
uartile Range
,49
ness
1,748
,337
sis
4,267
,662
1,2187
,05904
Confidence Interval for Mean
Bound
1,0979
Bound
1,3394
mmed Mean
1,2109
n
1,1200
ce
,105
eviation
,32337
um
,56
mum
1,91
e
1,35
uartile Range
,32
ness
,842
,427
sis
,412
,833
1,5312
,06300
Confidence Interval for Mean
Bound
1,4046
Bound
1,6578
mmed Mean
1,4858
n
1,3950
ce
,198
eviation
,44544
um
,99
mum
3,33
e
2,34
uartile Range
,48
ness
1,887
,337
sis
4,865
,662
98,70
23,336
UI/L)
Confidence Interval for Mean
Bound
50,97
Bound
146,43
mmed Mean
83,00
n
40,00
ce
16337,321
eviation
127,818
um
6
mum
530
e
524
uartile Range
161
ness
1,927
,427
sis
3,535
,833
179,44
29,603
Confidence Interval for Mean
Bound
119,95
Bound
mmed Mean
238,93
157,39
n
68,00
ce
43817,680
eviation
209,327
um
10
mum
901
e
891
uartile Range
186
ness
1,675
,337
sis
2,111
,662
54,77
12,475
unit/L)
Confidence Interval for Mean
Bound
29,25
Bound
80,28
mmed Mean
45,00
n
26,50
ce
eviation
4668,737
68,328
um
8
mum
346
e
uartile Range
ness
sis
338
48
2,993
,427
11,014
,833
54,54
5,760
Confidence Interval for Mean
Bound
42,96
Bound
66,12
mmed Mean
50,10
n
45,50
ce
1659,070
eviation
40,732
um
9
mum
236
e
227
uartile Range
36
ness
2,262
,337
sis
7,182
,662
1,8832
,18051
Confidence Interval for Mean
Bound
1,5141
Bound
2,2524
mmed Mean
1,7985
n
1,6895
ce
eviation
,977
,98869
um
,53
mum
5,00
e
4,47
uartile Range
1,14
ness
1,423
,427
sis
2,710
,833
2,6404
Confidence Interval for Mean
Bound
2,0769
Bound
3,2039
mmed Mean
2,3844
n
1,9055
ce
,28042
3,932
eviation
1,98287
um
,89
mum
10,14
e
9,26
uartile Range
1,69
ness
2,181
,337
sis
4,884
,662
5,37487
,535786
Q
Confidence Interval for Mean
Bound
4,27906
Bound
6,47067
mmed Mean
5,25819
n
5,52800
ce
eviation
8,612
2,934619
um
1,120
mum
12,606
e
uartile Range
11,486
5,471
ness
,327
,427
-,359
,833
24,45946
2,999681
sis
Confidence Interval for Mean
Bound
18,43138
Bound
30,48754
mmed Mean
21,77569
n
17,49100
ce
449,904
eviation
21,210945
um
7,082
mum
110,424
e
103,342
uartile Range
18,289
ness
2,240
,337
sis
5,508
,662
Tests of Normality
a
Kolmogorov-Smirnov
Statistic
ibu/ul)
in Total (mg/dl)
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
,096
30
,200
*
,979
30
,790
,104
50
,200
*
,956
50
,061
,142
30
,125
,888
30
,004
,233
50
,000
,754
50
,000
,348
30
,000
,621
30
,000
unit/L)
in (g/L)
etik)
UI/L)
unit/L)
Q
is a lower bound of the true significance.
efors Significance Correction
,238
50
,000
,690
50
,000
,275
30
,000
,701
30
,000
,265
50
,000
,664
50
,000
,203
30
,003
,849
30
,001
,165
50
,002
,956
50
,063
,200
30
,003
,902
30
,009
,157
50
,004
,856
50
,000
,219
30
,001
,880
30
,003
,156
50
,004
,837
50
,000
,340
30
,000
,708
30
,000
,277
50
,000
,737
50
,000
,297
30
,000
,624
30
,000
,189
50
,000
,794
50
,000
,165
30
,036
,895
30
,006
,193
50
,000
,738
50
,000
,113
30
,200
*
,959
30
,287
,225
50
,000
,735
50
,000
T-Test
Group Statistics
N
Mean
Std. Deviation
td. Error Mean
30
51,00
13,620
2,487
50
51,52
10,205
1,443
Independent Samples Test
vene's Test for
Equality of
Variances
F
variances
assumed
variances
not
assumed
Sig.
1,703
t-test for Equality of Means
t
,196
Confidence Interval of
the Difference
Mean
Differen
2-tailed)
ce Error Difference ower
Upper
df
-,194
78
,846
-,520
2,677
-5,850
4,810
-,181
48,563
,857
-,520
2,875
-6,299
5,259
ROC Curve
Notes
t Created
20-JUN-2015 13:16:13
ments
OJECT\STATISTIK\PENY
DALAM\ADI\data dasar dr Adi.sav
Dataset
et1
>
t
>
ile
>
ows in Working Data File
g Value Handling
ion of Missing
80
defined missing values are treated as
missing.
Used
ics are based on all cases with valid data
for all variables in the analysis.
x
FibroQ BY katGroup (1)
T=CURVE(REFERENCE)
NT=SE COORDINATES
TERIA=CUTOFF(INCLUDE)
TESTPOS(LARGE)
DISTRIBUTION(FREE) CI(95)
SING=EXCLUDE.
rces
ssor Time
00:00:00,33
ed Time
00:00:00,33
Case Processing Summary
n Varises Esofagus
lid N (listwise)
a
50
ve
30
ve
r values of the test result variable(s) indicate
stronger evidence for a positive actual state.
positive actual state is besar.
Area Under the Curve
Test Result Variable(s): FibroQ
symptotic 95% Confidence Interval
Area
td. Error
,963
a
ymptotic Sig.
,018
der the nonparametric assumption
hypothesis: true area = 0.5
b
Lower Bound
,000
Upper Bound
,928
,997
Coordinates of the Curve
Test Result Variable(s): FibroQ
ive if Greater Than or
Equal To
a
Sensitivity
1 - Specificity
,12000
1,000
1,000
1,14400
1,000
,967
1,39950
1,000
,933
1,66200
1,000
,900
1,78050
1,000
,867
1,87400
1,000
,833
1,96400
1,000
,800
2,21250
1,000
,767
3,01950
1,000
,733
3,67050
1,000
,700
3,96900
1,000
,667
4,32700
1,000
,633
4,54400
1,000
,600
4,73150
1,000
,567
5,12450
1,000
,533
5,52800
1,000
,500
5,64800
1,000
,467
5,95800
1,000
,433
6,22750
1,000
,400
6,47250
1,000
,367
6,72550
1,000
,333
6,92300
1,000
,300
7,09700
,980
,300
7,12100
,960
,300
7,13100
,940
,300
7,40000
,940
,267
7,69100
,920
,267
7,81700
,920
,233
7,99050
,920
,200
8,25200
,920
,167
8,49550
,920
,133
8,54850
,900
,133
8,56050
,900
,100
8,58850
,880
,100
8,78600
,860
,100
8,97900
,860
,067
9,14050
,840
,067
9,61000
,820
,067
9,94000
,820
,033
10,07950
,800
,033
10,55700
,780
,033
10,94050
,760
,033
11,15600
,740
,033
11,43150
,720
,033
11,53700
,700
,033
12,07650
,680
,033
12,80750
,680
,000
13,03250
,660
,000
13,41650
,640
,000
13,89750
,620
,000
14,59600
,600
,000
15,75250
,580
,000
16,66450
,560
,000
17,15950
,540
,000
17,34800
,520
,000
17,49100
,500
,000
17,69800
,480
,000
17,86300
,460
,000
18,13200
,440
,000
18,85700
,420
,000
19,41350
,400
,000
19,67950
,380
,000
21,75600
,360
,000
23,95800
,340
,000
24,71050
,320
,000
25,68600
,300
,000
27,64250
,280
,000
29,02200
,260
,000
29,46050
,240
,000
31,73000
,220
,000
34,21600
,200
,000
34,94200
,180
,000
36,00950
,160
,000
37,92350
,140
,000
43,85350
,120
,000
52,75050
,100
,000
63,55700
,080
,000
73,49400
,060
,000
76,57200
,040
,000
93,52400
,020
,000
111,42400
,000
,000
smallest cutoff value is the minimum observed test value minus 1, and the largest cutoff value is the maximum
observed test value plus 1. All the other cutoff values are the averages of two consecutive ordered observed
test values.
katFQ * KG2 Crosstabulation
KG2
besar
hin KG2
6
hin KG2
hin KG2
kecil
Total
45
3
48
90,0%
10,0%
60,0%
5
27
32
10,0%
90,0%
40,0%
50
30
80
100,0%
100,0%
100,0%
Data Hasil
Penelitian
Lampiran 6
No
Nama
Umur
L/P
MR
Plt.(10/L)
Bil. Total
AST
Albumin
1
Aman Sidabutar
52
1
586933
57
1,2
44
2,4
2
Arifin Silitonga
52
1
596253
342
0,65
18
3,1
3
Enda Malam
40
2
593761
23
2,11
61
1,6
4
Johanis T
45
1
593411
36
4,71
120
1,6
5
Momen
54
1
5946S4
89
1,36
62
2
6
Netti
47
2
588439
60
9,83
1075
2,9
7
Paristono
58
1
589213
72
2,53
200
2,9
8
Sehat Purba
40
1
587426
138
5,43
367
3,1
9
Sofi Yusrizal
36
2
595655
102
0,36
23
2,3
10
Sukiman
48
1
592770
62
7,31
166
2,1
11
Syafiah
53
1
590663
90
0,98
41
2
12
Erisa br Siahaan
58
2
620072
33
0,62
18
2
13
Hedwar Sibarani
49
1
559465
70
5,13
88
2,1
14
Herman
41
1
613573
83
2,11
155
2,5
15
Irianto
61
1
410716
94
4,66
142
2,7
16
Jimmy Panjaitan
36
1
548819
66
2,66
47
1,9
17
Joni Indra
43
1
621147
73
14,96
526
3,8
18
Juandy Marpaung
33
1
605427
433
0,73
15
4,5
19
Kasume Tambunan
53
1
600820
61
0,78
82
2,6
20
M.Syahni
41
1
602903
44
1,25
22
2,2
21
Tetap
52
1
606204
363
8,8
111
2,9
22
Abd Thalib
57
1
577673
184
0,3
20
4,9
23
Ahmad Kasrun
52
1
555770
118
27,57
125
1,6
24
Andi Ramadani
23
1
582156
266
16,9
320
2
25
Apul Sidabutar
61
1
5438?8
190
3,91
731
2
26
Arifin
41
1
570102
120
1,3
35
2
27
Aripin Bancin
43
1
620310
112
2,02
176
3,1
28
Armen Sembiring
53
1
548865
87
1,49
36
1,5
29
Asmara Sitompul
72
1
617861
207
10,63
175
2,6
30
Marulak Nadeak
50
1
612247
68
7,63
343
2,1
31
Baini
51
1
555380
65
0,68
29
2,7
32
Bun Ngials
54
1
623008
121
2,17
33
1,7
33
Darmadi Hutagaol
43
1
604612
108
11,26
175
2,1
34
Daud Simarmata
53
1
618951
139
3,58
40
1,7
35
Dedi Tarigan
46
1
585645
75
20,34
100
1,6
36
Mariono Lesmana
44
1
605782
135
0,43
12
2,7
37
Misbah Udin
42
1
611412
180
1,19
50
0,5
38
Nisma Siregar
55
2
597747
154
0,25
31
2,8
39
Nurmansyah
38
1
602557
204
1,37
284
3,4
40
Ponimin
39
1
610014
46
0,89
42
2,9
41
Rasyad Lubis
65
1
609517
406
31,64
506
2,1
42
Kantin Barus
49
2
622248
386
27,55
217
2,9
43
Koko Saputra
48
1
627279
111
6,04
94
2,9
44
Krisna
40
1
617442
60
8,6
53
2,2
45
Lisria Sitanggang
51
2
614437
117
2,78
123
1,9
46
Lidia Siahaan
72
2
594014
674
0,38
47
3,1
47
Mestiana sinurat
41
2
622241
73
0,9
76
2
48
Roshidawati S
48
2
622854
70
7,35
179
2,5
49
Rusli Sitepu
58
1
625504
126
6,18
89
2,1
50
Salomo Sitepu
49
1
614686
187
1,29
67
2,5
51
Sanimin
64
1
620531
68
11,92
128
1,5
52
Selamat saragih
72
1
624881
134
1,13
75
2,4
53
Sri Wondo
54
2
620866
135
2,47
84
1,8
54
Wasina
55
2
625334
245
0,78
43
2,3
55
Aliaman Tambunan
62
1
628170
258
2,79
52
2,8
56
Ngatiah
57
2
547023
271
1,11
92
2,9
57
Suhery
44
1
511721
199
1,19
68
2,7
58
Ardiansyah
26
1
553523
431
1,14
110
2,9
59
Oberlin
46
1
941908
35
2,26
35
2,9
60
Wagini
88
2
618409
261
14,97
267
2,4
61
M.saleh
57
1
630138
79
0,73
40
2,1
62
Uparis simamora
60
1
459933
78
0,56
62
3,7
63
Sirus muthe
61
1
612826
112
1,31
18
2,4
64
Sarachsi
69
1
629841
59
2,51
124
2,5
65
Soden ginting
70
1
631722
79
3,22
110
2,8
66
Parlindungan S
46
1
632846
343
0,28
23
2,5
67
Wilson S
57
1
593013
715
21,17
93
2
68
Z.Bukhari
59
1
608665
404
0,15
26
2,3
69
Naimah nuri P
63
2
504960
53
0,89
35
2,9
70
Zunaidah
49
2
615783
39
3,94
69
2
71
Toguan
45
1
628699
389
2,82
489
3,1
72
Sudarto
46
1
588844
87
0,8
18
4
73
Hotmaida
42
2
619717
72
8,97
38
2,1
74
Arifin Nasution
52
1
597758
93
1,24
19
2,9
75
Arjuna Tarigan
57
1
553344
249
17,9
306
2,3
76
Edi Susanto
45
1
564224
340
32,18
491
2,1
77
Maria
64
2
600631
161
0,64
74
2,8
78
Katiman
85
1
618126
132
2,25
35
2,9
79
Nuzul Indra
33
1
624720
240
3,46
241
3,1
80
Rohana
48
2
620214
87
1,17
46
2,8
Keterangan :
*) Jenis Kelamin
*) Asites
*) CP (Child Pugh)
Laki-laki
=1
Tidak ada Asites
Perempuan
=2
Asites minimal
=1
B (Sedang)
Asites sedang
=2
C (Berat)
Asites berat
=3
*) Hepatic Encephalopathy
(HE)
=0
A (Ringan)
*) Etiologi SH
Tidak ada HE
=0
Bukan Hep.B&C
HE grade 1
=1
Hep.B
HE grade 2
=2
Hep.C
Hep.B&C
INR
Asites
HE
CP
Etio.SH
ø VE
Grup ø
ALT
FibroQ
1,58
2
0
3
0
2
2
9
70,468
0,99
1
0
1
0
1
1
16
1,693
1,75
3
1
3
1
2
2
38
48,855
1,58
3
0
3
1
2
2
61
38,852
1,34
2
0
2
1
3
2
26
19,387
1,39
2
0
3
0
2
2
106
110,424
1,24
2
0
2
1
3
2
54
36,995
1,5
3
0
3
1
2
2
55
29,011
1,08
1
0
1
0
1
1
16
5,479
1,74
1
0
3
1
2
2
127
17,607
1,48
2
0
3
1
2
2
31
11,527
1,19
2
0
2
2
3
2
15
25,098
2,09
2
0
3
0
2
2
49
26,274
1,09
2
0
2
1
3
2
55
15,174
2,11
2
0
3
1
3
2
100
19,44
1,72
2
2
3
0
2
2
27
16,331
1,63
2
0
3
1
2
2
66
76,52
1,47
1
0
1
0
1
1
15
1,12
1,72
2
0
3
3
2
2
41
29,888
1,4
1
0
2
0
3
2
16
17,937
1,14
2
0
3
1
1
1
38
4,77
1,1
1
0
1
0
1
1
16
4,259
3,33
2
0
3
0
3
2
141
13,009
1,8
2
0
3
0
1
1
136
3,662
1,14
2
0
3
1
2
2
236
11,336
1,1
2
0
2
1
1
1
23
5,719
1,26
2
0
2
1
2
2
49
17,375
1,35
3
0
2
0
2
2
29
10,209
1,16
2
0
3
2
2
2
76
9,29
0,99
2
0
3
1
3
2
86
29,033
1,1
1
0
2
0
1
1
37
6,764
1,04
2
0
3
1
1
1
19
8,061
1,92
1
0
2
1
2
2
55
24,323
1,59
2
0
3
0
2
2
21
11,547
2,17
3
0
3
1
3
2
38
35,024
0,96
1
0
1
0
1
1
8
4,693
1,45
3
0
3
1
2
2
17
9,95
0,93
2
0
2
0
1
1
13
7,92
1,23
1
0
1
1
1
1
105
6,197
0,99
2
0
2
1
3
2
27
13,056
1,28
2
0
3
1
2
2
61
16,998
0,56
2
0
3
0
1
1
132
1,168
0,93
1
0
2
1
1
1
49
7,714
1,04
1
0
3
0
1
1
37
9,93
2,1
2
0
3
1
2
2
65
17,321
1,02
2
0
2
0
1
1
25
2,048
1,26
1
2
3
1
2
2
49
10,976
1,73
3
0
3
1
3
2
90
23,593
1,7
3
0
3
1
3
2
38
18,327
1
1
0
2
0
1
1
35
5,577
2,21
2
0
3
1
2
2
47
56,646
1,32
1
0
2
2
1
1
85
6,258
1,85
1
0
3
1
2
2
57
10,905
1,86
1
0
2
1
1
1
21
8,549
1,22
1
0
2
0
1
1
17
8,967
0,96
1
0
1
1
1
1
22
8,443
1,4
1
0
2
1
1
1
129
1,631
1,22
1
0
1
1
1
1
22
3,679
1,44
1
0
2
1
2
2
19
34,86
1,03
2
0
2
0
1
1
130
7,132
1,36
2
0
2
1
2
2
28
14,018
1,3
2
0
1
0
2
2
45
13,777
1,91
2
0
2
1
1
1
28
6,687
1,12
2
0
2
0
2
2
65
19,919
1,24
2
0
2
1
2
2
36
33,572
1,71
0
0
1
0
1
1
12
4,395
1,86
2
0
2
0
1
1
58
2,377
1,23
0
0
1
0
1
1
25
1,868
1,24
2
0
1
1
2
2
29
17,789
2,74
0
0
2
0
2
2
31
76,624
1,15
2
0
2
1
1
1
346
1,88
1,2
1
0
2
1
3
2
16
7,13
1,28
2
0
3
0
3
2
37
7,668
1,4
2
0
2
0
3
2
21
7,082
1,29
3
0
3
1
2
2
105
8,605
1,39
2
0
3
1
2
2
127
7,112
1,2
1
0
1
0
1
1
28
12,606
1,1
2
0
2
0
2
2
29
8,548
1,19
2
0
2
1
2
2
46
8,572
1,24
2
0
2
0
3
2
35
8,991
*) ø
Varices Esophagus)
=1
F1
=
1
=2
F2
=
2
=3
F3
=
3
VE (Varices
esipagus)
*) Grup ø
=0
Kecil
=
1
=1
Besar
=
2
=2
=3